Literature DB >> 29708138

Zebrafish as experimental model to establish the contribution of mutant p53 and ID4 to breast cancer angiogenesis in vivo.

Magdalena Pruszko1, Elisa Milano2, Alicja Zylicz1, Maciej Zylicz1, Giovanni Blandino2, Giulia Fontemaggi2.   

Abstract

Entities:  

Year:  2018        PMID： 29708138      PMCID： PMC5906282          DOI： 10.21037/jtd.2018.03.86

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  7 in total

Review 1.  Imaging Cancer Angiogenesis and Metastasis in a Zebrafish Embryo Model.

Authors:  C Tulotta; S He; W van der Ent; L Chen; A Groenewoud; H P Spaink; B E Snaar-Jagalska
Journal:  Adv Exp Med Biol       Date:  2016       Impact factor: 2.622

2.  Mammalian tumor xenografts induce neovascularization in zebrafish embryos.

Authors:  Stefania Nicoli; Domenico Ribatti; Franco Cotelli; Marco Presta
Journal:  Cancer Res       Date:  2007-04-01       Impact factor: 12.701

3.  The mutant p53-ID4 complex controls VEGFA isoforms by recruiting lncRNA MALAT1.

Authors:  Magdalena Pruszko; Elisa Milano; Mattia Forcato; Sara Donzelli; Federica Ganci; Silvia Di Agostino; Simone De Panfilis; Francesco Fazi; David O Bates; Silvio Bicciato; Maciej Zylicz; Alicja Zylicz; Giovanni Blandino; Giulia Fontemaggi
Journal:  EMBO Rep       Date:  2017-06-26       Impact factor: 8.807

4.  Development of Potent, Selective SRPK1 Inhibitors as Potential Topical Therapeutics for Neovascular Eye Disease.

Authors:  Jennifer Batson; Hamish D Toop; Clara Redondo; Roya Babaei-Jadidi; Apirat Chaikuad; Stephen F Wearmouth; Brian Gibbons; Claire Allen; Cynthia Tallant; Jingxue Zhang; Chunyun Du; Jules C Hancox; Tom Hawtrey; Joana Da Rocha; Renate Griffith; Stefan Knapp; David O Bates; Jonathan C Morris
Journal:  ACS Chem Biol       Date:  2017-02-06       Impact factor: 5.100

Review 5.  Zebrafish as an Emerging Model Organism to Study Angiogenesis in Development and Regeneration.

Authors:  Myra N Chávez; Geraldine Aedo; Fernando A Fierro; Miguel L Allende; José T Egaña
Journal:  Front Physiol       Date:  2016-03-08       Impact factor: 4.566

Review 6.  Mutant p53 in cancer: new functions and therapeutic opportunities.

Authors:  Patricia A J Muller; Karen H Vousden
Journal:  Cancer Cell       Date:  2014-03-17       Impact factor: 31.743

7.  TCGASpliceSeq a compendium of alternative mRNA splicing in cancer.

Authors:  Michael Ryan; Wing Chung Wong; Robert Brown; Rehan Akbani; Xiaoping Su; Bradley Broom; James Melott; John Weinstein
Journal:  Nucleic Acids Res       Date:  2015-11-23       Impact factor: 16.971
  7 in total
  3 in total

1.  A somatic mutation of RasGRP3 decreases Na+/I- symporter expression in metastases of radioactive iodine-refractory thyroid cancer by stimulating the Akt signaling pathway.

Authors:  Jianlu Song; Wangwang Qiu; Xianzhao Deng; Zhongling Qiu; Youben Fan; Zhili Yang
Journal:  Am J Cancer Res       Date:  2018-09-01       Impact factor: 6.166

2.  MALAT1-dependent hsa_circ_0076611 regulates translation rate in triple-negative breast cancer.

Authors:  Chiara Turco; Gabriella Esposito; Alessia Iaiza; Frauke Goeman; Anna Benedetti; Enzo Gallo; Theodora Daralioti; Letizia Perracchio; Andrea Sacconi; Patrizia Pasanisi; Paola Muti; Claudio Pulito; Sabrina Strano; Zaira Ianniello; Alessandro Fatica; Mattia Forcato; Francesco Fazi; Giovanni Blandino; Giulia Fontemaggi
Journal:  Commun Biol       Date:  2022-06-16

3.  Paracrine Signaling from Breast Cancer Cells Causes Activation of ID4 Expression in Tumor-Associated Macrophages.

Authors:  Sara Donzelli; Andrea Sacconi; Chiara Turco; Enzo Gallo; Elisa Milano; Ilaria Iosue; Giovanni Blandino; Francesco Fazi; Giulia Fontemaggi
Journal:  Cells       Date:  2020-02-11       Impact factor: 6.600
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.